Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Guinea Pig Blinking Test: a comparison with human responses

A Bar-Ilan1

  • 1Pharmos, Ltd., Kiryat Weizmann, Rehovot, Israel.

Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro characterization of MOD-5014, a novel long-acting carboxy-terminal peptide (CTP)-modified activated FVII.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

Binding and activation of thiamin diphosphate in acetohydroxyacid synthase.

Biochemistry·2001
Same author

Pharmacology of the intraocular pressure (IOP) lowering effect of systemic dexanabinol (HU-211), a non-psychotropic cannabinoid.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2000
Same author

Circadian rhythm of heart rate variability is reversibly abolished in ischemic stroke.

Stroke·1998
Same author

Beta3-adrenergic relaxation of bovine iris sphincter.

FEBS letters·1998
Same author

Diurnal variations in intraocular pressure in the albino rabbit: relationship to morning intraocular pressure.

Ophthalmic research·1997

The Guinea Pig Blinking Test effectively predicts human ocular discomfort from ophthalmic drugs. This animal model shows a strong correlation with human pain perception, aiding in the development of comfortable eye formulations.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Animal Models

Background:

  • Ocular formulation comfort is crucial for patient compliance.
  • Developing ophthalmic drugs requires reliable methods to assess ocular discomfort.
  • The Guinea Pig Blinking Test was proposed as a model for evaluating ocular formulation comfort.

Purpose of the Study:

  • To compare human nociceptive responses with guinea pig blinking responses to varying concentrations of sulfacetamide.
  • To validate the Guinea Pig Blinking Test as a predictive model for ocular discomfort.

Main Methods:

  • Human subjects reported pain upon instillation of different sulfacetamide concentrations.
  • Guinea pigs' blinking responses were measured after topical application of sulfacetamide (2.5%-17.5%) and saline.

Related Experiment Videos

  • A Blinking Index (B.I.) was calculated by comparing drug-induced blinks to saline-induced blinks.

    • Main Results:

    • Human and guinea pig dose-response curves for sulfacetamide were nearly identical.
    • A threshold for discomfort was observed at 5% sulfacetamide, with a linear increase up to 12.5%-15%.
    • A 2.5% sulfacetamide solution causing pain in 10% of humans yielded a B.I. of 1.04; a 12.5% solution causing pain in 95% of humans yielded a B.I. of 1.61.

    Conclusions:

    • The Guinea Pig Blinking Test demonstrates a strong linear relationship with human perception of ocular pain.
    • This animal model is a valuable tool for predicting ocular discomfort associated with topical ophthalmic drugs.
    • The findings support the use of the Guinea Pig Blinking Test in the selection and development of comfortable ocular formulations.